MedTrace Logo

Focal Radiotherapy for Previously Treated Prostate Cancer Patients

NCT03073278 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-02-06

No results posted yet for this study

Summary

To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.

Conditions

  • Locally Recurrent Prostate Cancer

Interventions

RADIATION

Stereotactic Body Radiotherapy

Each group will have different dose of stereotactic body radiotherapy (SBRT). Depending on which group patients are in.

Sponsors & Collaborators

  • Northern Sydney and Central Coast Area Health Service

    collaborator OTHER

  • Royal North Shore Hospital

    lead OTHER

Principal Investigators

  • George Hruby · Northern Sydney Local Health District

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03073278 on ClinicalTrials.gov